Bioequivalence-approved drugs top 6,410 in September

Published: 2013-09-27 06:59:00

Updated: 2013-09-27 06:59:00

The number of bioequivalence drugs and their reference drugs, which was approved by the Ministry of Food and Drug Safety, came to 6,410 in September, up 224 compared to 6,145 in April, a government data showed Wednesday.

The Health Insurance Review and Assessment Service (HIRA) said some finan...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK